Study Finds That 39 Million People Could Die From Antibiotic-Resistant Infections in Next 25 Years
According to a study published in The Lancet, more than 39 million people worldwide could die from antibiotic-resistant infections over the next 25 years.
The study also reveals that “more than one million people died each year as a result of AMR between 1990 and 2021. The study also estimates 1.91 million people could potentially die as a direct result of AMR in 2050, an increase of almost 70% per year compared to 2022. Over the same period, the number of deaths in which AMR bacteria play a role will increase by almost 75% from 4.71 million to 8.22 million per year.”
The first study led by the Global Research on Antimicrobial Resistance (GRAM) Project, published in 2022, found that “global AMR-related deaths in 2019 were higher than those from HIV/AIDS or malaria, leading directly to 1.2 million deaths and playing a role in a further 4.95 million deaths.”
Based on historical trends, the authors of the new study found that trends in AMR deaths “underwent a major age-related shift” from 1990 to 2021, “with those among children under five years old decreasing by more than 50%” and those “among adults 70 years or older increased by more than 80%.”
Deaths due to methicillin-resistant S. aureus (MRSA) “increased the most globally, leading directly to 130,000 deaths in 2021 – more than doubling from 57,200 in 1990.”
About the Author
Matt MacKenzieMatt MacKenzie
Associate Editor
Matt MacKenzie is Senior Staff Writer and Associate Editor of Healthcare Purchasing News (HPN), where he leads daily news coverage and contributes in-depth features on healthcare supply chain, sterile processing, infection prevention and clinical operations. Through industry reporting and expert interviews, he examines the trends, technologies and operational challenges shaping healthcare purchasing and patient care.
Related
antimicrobial_resistance
